Individualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice: A randomized-clinical trial

Figure 3 No significant difference was found in the mean length of time spent in remission or active disease throughout 1 year for the two screening procedures of fecal calprotectin, illustrated with an enlarged circle and cross. The length of time spent in FC remission (green), moderate activity (yellow), and severe activity (red) by each patient is represented by small circles (on demand) and crosses (every third month). The distance (perpendicular) from a small circle or cross within the triangle to a side of the triangle represents the length of time spent in that FC zone. FC: Fecal calprotectin.